Neoleukin Therapeutics, Inc. Announces Management Changes
Also on February 25, 2022, the Board appointed Martin Babler, a member of the Board, to serve as Chairperson of the Compensation Committee, effective
as of the Effective Date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.71 USD | -1.25% | -2.49% | +63.62% |
1st Jan change | Capi. | |
---|---|---|
+63.62% | 413M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |